Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted Average): 2010-2021
Historic Shares Outstanding (Diluted Average) for Neurocrine Biosciences (NBIX) over the last 8 years, with Sep 2021 value amounting to $97.9 million.
- Neurocrine Biosciences' Shares Outstanding (Diluted Average) fell 0.10% to $97.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $97.9 million, marking a year-over-year decrease of 0.10%. This contributed to the annual value of $97.8 million for FY2020, which is 0.62% up from last year.
- Per Neurocrine Biosciences' latest filing, its Shares Outstanding (Diluted Average) stood at $97.9 million for Q3 2021, which was down 0.10% from $98.0 million recorded in Q2 2021.
- Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) peaked at $98.2 million during Q2 2020, and registered a low of $87.3 million during Q1 2017.
- Over the past 3 years, Neurocrine Biosciences' median Shares Outstanding (Diluted Average) value was $97.8 million (recorded in 2020), while the average stood at $96.8 million.
- In the last 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) climbed by 6.86% in 2017 and then fell by 0.20% in 2021.
- Over the past 5 years, Neurocrine Biosciences' Shares Outstanding (Diluted Average) (Quarterly) stood at $92.7 million in 2017, then rose by 2.96% to $95.4 million in 2018, then climbed by 1.89% to $97.2 million in 2019, then climbed by 0.62% to $97.8 million in 2020, then decreased by 0.10% to $97.9 million in 2021.
- Its Shares Outstanding (Diluted Average) stands at $97.9 million for Q3 2021, versus $98.0 million for Q2 2021 and $98.2 million for Q1 2021.